Wink
Venture Round in 2023
Wink is a developer of a multifactor biometric identity and payments platform that leverages advanced facial and voice recognition technology, artificial intelligence, and machine learning. The platform is designed to facilitate fast, secure, passwordless login and payment experiences, eliminating the need for traditional passwords and lengthy forms. Wink's innovative approach has led to several patents pending, specifically in the fields of biometric authentication for e-commerce, retail, and car payments. The payments platform supports a variety of major payment methods, including credit and debit cards, as well as popular digital wallets, and can process biometric payments through over 200 major gateways. Additionally, Wink's technology ensures data protection through advanced network tokenization and compliance with PCI standards, aiming to provide a fraud-free payment environment for customers.
IDBiologics
Venture Round in 2020
IDBiologics is a biotechnology company that develops human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases. Its proprietary antibody platform enables rapid discovery and optimization of broad, potent therapeutic molecules, delivering extensive capability to isolate antibodies for varied infectious disease targets. Lead candidate molecules across diverse targets are advancing toward development, with the goal of expanding options to treat, prevent, and cure infectious diseases.
Matchwell
Venture Round in 2020
Matchwell LLC, established in 2017 and headquartered in Durham, North Carolina, operates an online marketplace that connects clinicians with healthcare facilities. The platform allows clinicians to join facility pools of their choice, view available shift information, and communicate directly with hiring managers. With over 50,000 registered clinicians and more than 1,000 contracted sites of care, Matchwell facilitates efficient workforce management by leveraging AI for transparency and flexibility in healthcare staffing arrangements.
Pops Diabetes Care
Series A in 2019
Pops Diabetes Care offers a virtual healthcare platform for people with diabetes. It uses consumer-centric sensors and AI-driven virtual coaches to help users manage their condition effectively, leading to potential savings of over $2,000 annually per user.
IPwe, Inc. is a global financial technology company based in Dallas, Texas, with an additional office in Paris, France. Founded in 2018, the company operates an online platform that connects buyers and sellers of patents while offering a variety of patent-related services. These services include patent financing, analytics, sales, licensing, and management of standard essential patents as well as annuity payments. IPwe serves a diverse clientele, including patent owners, service providers, lenders, investors, corporations, legal professionals, and individuals. The company's mission is to transform the intellectual property landscape by providing businesses with insights into their patent portfolios from a financial perspective, thereby facilitating informed decision-making to enhance value and drive innovation.